Total viable count (TVC) determination, also known as aerobic plate count (APC) testing, is a fundamental microbiological quality control test for Nisin A and Nisin Z preparations, the bacteriocin food preservatives (E234 / INS 234) produced by Lactococcus lactis and widely used in dairy, canned, and processed food products. This technical article explains the applicable standards (ISO 4833-1, GB 4789.2, FDA BAM), sample preparation, inoculation and incubation procedures, colony counting and calculation, and the special methodological considerations required to neutralize the intrinsic antimicrobial activity of nisin during enumeration. It is intended for food additive manufacturers, quality assurance managers, and accredited third-party laboratories involved in the release testing and regulatory compliance of Nisin A/Z products.
Technical Overview
Nisin A and Nisin Z are ribosomally synthesized lantibiotic bacteriocins produced by certain strains of Lactococcus lactis subsp. lactis. Nisin Z differs from Nisin A by a single amino acid substitution (asparagine at position 27 in place of histidine), which gives it higher solubility and better diffusion properties at near-neutral pH. Commercial Nisin A/Z preparations are typically standardized to approximately 2.5% active nisin (about 1,000 IU/mg) and blended with carriers such as sodium chloride and non-fat milk solids, in accordance with international food additive specifications.
Because nisin is added directly to foods as a preservative, the microbiological load of the additive itself has a direct impact on the safety and shelf life of the finished food product. Total viable count determination measures the number of mesophilic, aerobic, and facultatively anaerobic microorganisms capable of forming colonies in a non-selective agar medium, and serves as the primary hygiene indicator for Nisin A/Z batches.
A distinctive technical challenge in this test is that nisin is itself a potent antimicrobial peptide. Residual nisin activity carried into the counting medium can inhibit the growth of contaminant organisms and lead to systematic underestimation of the true microbial load. Validated dilution and neutralization strategies are therefore an essential part of the method, together with recovery verification using spiked samples.
- Primary enumeration standards: ISO 4833-1 (pour plate at 30 °C), ISO 4833-2 (surface plating), GB 4789.2 (national food safety standard for aerobic plate count), and FDA BAM Chapter 3.
- Sample preparation standards: ISO 6887-1 for the preparation of test samples, initial suspensions, and decimal dilutions.
- Results are expressed as colony-forming units per gram (CFU/g) of the Nisin A/Z preparation.
Testing Samples
Bulk Nisin A/Z Raw Material Powder
Spray-dried or otherwise dried nisin bulk powder obtained directly from fermentation and downstream purification. This material represents the highest-risk stage for process contamination and is normally tested batch by batch before blending or release. Sampling should follow a statistically valid plan, with aseptic collection from multiple points of the container or bag liner.
Commercial Standardized Nisin Preparations
Finished, packaged Nisin A/Z products in which the active substance has been diluted with sodium chloride and non-fat milk solids to the standard commercial potency of approximately 1,000 IU/mg. Testing verifies that blending, milling, and filling operations have not introduced microbial contamination.
Retained Samples and Stability Study Samples
Retention samples from released batches and samples held under real-time or accelerated stability conditions (for example, 25 °C/60% RH or 40 °C/75% RH) are periodically tested for total viable count to confirm that the microbiological quality remains within specification throughout the declared shelf life.
Nisin-Containing Premixes and Carrier Blends
Custom formulations in which Nisin A/Z is pre-blended with salts, culture media components, or excipients for specific food applications. The same enumeration principles apply, with dilution factors adjusted for the expected microbial load of the carrier system.
Testing Items
The core testing item is the total viable count (aerobic plate count) of the Nisin A/Z sample, reported in CFU/g. In practice, total viable count testing is usually performed as part of a broader microbiological specification package for nisin products, which may include:
- Total viable count (aerobic plate count) at 30 °C or 36 °C – ISO 4833-1 / GB 4789.2.
- Enumeration of yeasts and molds – ISO 21527 series / GB 4789.15.
- Enumeration of coliforms and detection of Escherichia coli – ISO 4832 / GB 4789.3.
- Detection of Salmonella spp. – ISO 6579-1 / GB 4789.4.
- Detection of Staphylococcus aureus and other specified organisms where customer or regulatory specifications require.
Typical commercial and pharmacopoeial-style acceptance criteria for Nisin A/Z preparations set maximum total viable count limits in the range of 10² to 10³ CFU/g, combined with absence of specified pathogens in defined sample quantities. The exact limits are defined by the applicable product specification, customer agreement, or importing-market requirement.
Testing Methods
Sample Preparation and Serial Dilution
A representative test portion (commonly 10 g, or 5 g for reduced-volume protocols) is weighed aseptically and added to 9 times its mass of sterile diluent, such as peptone salt solution or buffered peptone water, to prepare a 1:10 initial suspension. The suspension is homogenized for 1 to 2 minutes using a stomacher or equivalent blender. Further decimal dilutions are prepared from this initial suspension in accordance with ISO 6887-1.
Because the minimum inhibitory concentration of nisin against susceptible test organisms is very low, serial dilution serves a dual purpose: it brings the expected colony number into the countable range and simultaneously reduces residual nisin activity in the plated aliquot to below inhibitory levels. Recovery studies using suspensions inoculated with known reference organisms should be performed during method validation to confirm that any residual bacteriocin activity does not suppress colony formation.
Inoculation and Incubation
For the pour plate technique, 1 mL of the appropriate dilution is transferred into each of at least two sterile petri dishes, and 12 to 20 mL of molten plate count agar (tryptone, yeast extract, glucose, agar), cooled to 44–47 °C, is added. The plates are mixed thoroughly and allowed to solidify on a cool, level surface. For the surface spread plate technique, 0.1 mL of dilution is spread onto pre-poured, dry plate count agar plates. Incubation conditions are as follows:
- ISO 4833-1: incubation at 30 ± 1 °C for 72 ± 3 hours, anaerobic or aerobic incubation as specified, inverted plates.
- GB 4789.2: incubation at 36 ± 1 °C for 48 ± 2 hours, inverted plates.
- FDA BAM alternative: incubation at 35 ± 1 °C for 48 ± 2 hours.
Colony Counting and Calculation
After incubation, colonies are counted using a colony counter on plates bearing colony numbers within the validated counting range — typically 15 to 300 colonies per plate under ISO 4833-1 and 30 to 300 colonies per plate under GB 4789.2. The total viable count is calculated from the arithmetic mean of replicate plates multiplied by the dilution factor, rounded to two significant figures, and reported as CFU/g. When no colonies are detected at the lowest dilution, the result is reported as less than the corresponding detection limit. Spreading colonies and plates that are uncountable due to overgrowth are handled according to the specific interpretation rules of the applied standard.
Quality Control and Neutralization Validation
Each analytical run includes sterility controls for the diluent and the medium, duplicate inoculation of all dilutions, and growth promotion testing of the culture medium with defined reference strains. Incubators are continuously monitored and calibrated, and laboratories performing this testing for regulatory purposes should operate under an ISO/IEC 17025 quality management system. In addition, the laboratory's validation file for Nisin A/Z should document recovery, precision, and robustness data demonstrating that the antimicrobial activity of the sample matrix has been adequately neutralized.
Applications
Total viable count determination for Nisin A/Z supports multiple quality, regulatory, and commercial objectives across the food supply chain:
- Batch release testing of bulk and finished Nisin A/Z products against internal or customer specifications.
- Regulatory compliance demonstration for nisin as a permitted food additive (E234 / INS 234) under frameworks such as the Codex General Standard for Food Additives, EU food additive regulations, the GB 2760 use provisions with corresponding GB 1886 series product specifications, and FDA GRAS requirements in the United States.
- Import and export inspection, where accredited third-party laboratories provide internationally recognized test reports for customs and market-surveillance authorities.
- Shelf-life and stability programs verifying that microbiological quality is maintained to the end of the declared re-test period.
- GMP, HACCP, and hygiene monitoring in fermentation, drying, blending, and packaging operations, including investigation of out-of-specification results and environmental contamination events.
- Supplier qualification and periodic audits of contract manufacturers and toll blenders.
FAQ
What is the difference between Nisin A and Nisin Z, and does it affect the test method?
Nisin A and Nisin Z differ by one amino acid residue at position 27; Nisin Z diffuses more effectively at neutral pH. Both variants are strongly antimicrobial, so both require the same dilution-based neutralization strategy and recovery validation during total viable count testing. The enumeration method itself is identical for both.
Why is total viable count testing important for a preservative product?
Although nisin inhibits many Gram-positive bacteria, it has little effect against Gram-negative organisms, yeasts, and molds, and its activity can degrade during processing or storage. A high total count in the additive can introduce spoilage organisms and opportunistic contaminants directly into food. TVC testing therefore confirms that the preservative itself meets hygienic manufacturing standards.
Which standard should be used: ISO 4833-1 or GB 4789.2?
The choice depends on the target market and the applicable specification. ISO 4833-1 (30 °C, 72 hours) is widely accepted for international trade and EU-aligned specifications, while GB 4789.2 (36 °C, 48 hours) is mandatory for products governed by Chinese national food safety standards. Accredited third-party laboratories routinely perform both and can advise on the appropriate method for a given regulatory context.
How is the antimicrobial activity of nisin prevented from interfering with the count?
Sufficient serial dilution reduces residual nisin in the plated aliquot to below its minimum inhibitory concentration. This is confirmed during method validation by inocating nisin sample suspensions with known quantities of reference microorganisms and verifying acceptable recovery. Where dilution alone is insufficient, validated medium adjustments or inactivation steps may be introduced, subject to documented verification.
What sample quantity and turnaround time should be expected?
A representative sample of typically 25 to 100 g per lot is recommended to allow the full microbiological panel with retain portions. The plate count portion of the analysis requires approximately 3 to 7 working days from receipt, including incubation, confirmation, and reporting, with longer lead times when pathogen detection tests are run in parallel.
How should results be interpreted against specification limits?
Results are compared with the maximum total viable count defined in the product specification, commonly in the range of 10² to 10³ CFU/g. Because plate counts are inherently variable, interpretation should follow the rounding and reproducibility rules of the applied standard, and any out-of-specification result should trigger a documented investigation covering sampling, methodology, and manufacturing records.